Your browser doesn't support javascript.
loading
Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC).
McNeel, Douglas G; Eickhoff, Jens C; Wargowski, Ellen; Johnson, Laura E; Kyriakopoulos, Christos E; Emamekhoo, Hamid; Lang, Joshua M; Brennan, Mary Jane; Liu, Glenn.
Afiliación
  • McNeel DG; Department of Medicine, Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, USA dm3@medicine.wisc.edu.
  • Eickhoff JC; Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Wargowski E; Department of Medicine, Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Johnson LE; Department of Medicine, Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Kyriakopoulos CE; Department of Medicine, Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Emamekhoo H; Department of Medicine, Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Lang JM; Department of Medicine, Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Brennan MJ; Department of Medicine, Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Liu G; Department of Medicine, Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, USA.
J Immunother Cancer ; 10(3)2022 03.
Article en En | MEDLINE | ID: mdl-35277461
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas de ADN / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Clinical_trials Límite: Humans / Male Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas de ADN / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Clinical_trials Límite: Humans / Male Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido